MedPath

Feasibility of hybrid-technology upper limb rehabilitation for people with neurological impairments in hospital.

Not Applicable
Recruiting
Conditions
pper limb impairment from neurological disorder
Upper limb impairment from neurological disorder
Stroke - Haemorrhagic
Stroke - Ischaemic
Neurological - Multiple sclerosis
Neurological - Parkinson's disease
Neurological - Other neurological disorders
Registration Number
ACTRN12622001564741
Lead Sponsor
The University of Queensland
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Rehabilitation inpatients with neurological upper limb impairment caused by stroke (first or recurrent), traumatic or other acquired brain injury, spinal cord injury or other stable neurological condition with sufficient English to provide informed consent and cognitive function to follow instructions during group therapy sessions and the study.

Exclusion Criteria

Admitted rehabilitation inpatients with the following will be excluded - motor neuron disease or other deteriorating neurological conditions, patients in post-traumatic amnesia, patients with upper limb disorders from congenital conditions and people with upper limb amputations.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patient self-reported outcome measure of arm function using Arm Activity Measure (Arm-A).[ Baseline and inpatient discharge.];Upper limb impairment measure using Fugl-Meyer Assessment-Upper Extremity.[ Baseline and inpatient discharge.];Upper limb activity measure using Action Research Arm Test.[ Baseline and inpatient discharge.]
Secondary Outcome Measures
NameTimeMethod
Participation outcome measure using Community Integration Questionnaire-Revised. (Primary outcome).[ Baseline and inpatient discharge.];Feasibility outcome addressing intervention acceptability using survey designed specifically for this study. [ At inpatient discharge.];Feasibility outcome addressing therapy engagement using Pittsburgh Participation Rating Scale. [ At each upper limb therapy group session.];Feasibility outcome addressing implementation via attendance rates using study data collection form for therapy attendance. [ At each upper limb therapy group session.];Feasibility outcome addressing implementation via therapy intensity (time, repetitions) using <br>study data collection form for therapy dosage. [ At each upper limb therapy group session.];Feasibility outcome addressing intervention efficacy through goal attainment and quality of life (EQ-5D-5L). [ At inpatient discharge]
© Copyright 2025. All Rights Reserved by MedPath